Results 131 to 140 of about 58,845 (265)

Role of the median preoptic nucleus in the chronic hypotensive effect of losartan in sodium‐replete normal rats [PDF]

, 2009
Trasida Ployngam, Stephen S Katz, John P. Collister   +2 more
openalex   +1 more source

Angiotensin-II receptor blockade in Marfan syndrome [PDF]

, 2019
De Backer, Julie, Muiño Mosquera, Laura
core   +2 more sources

P3–069: Losartan‐induced hypotension impairs learning and memory [PDF]

, 2013
Xinghua Liu, Xiji Shu
openalex   +1 more source

Supplementary Table S5 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3⁺ Cancer Cells in Locally Advanced Pancreatic Cancer

, 2023
Yves Boucher, Jessica M. Posada, Sonu Subudhi, Ashwin S. Kumar, Spencer R. Rosario, Liqun Gu, Heena Kumra, Mari Mino–Kenudson, Nilesh P. Talele, Dan G. Duda, Dai Fukumura, Jennifer Y. Wo, Jeffrey W. Clark, David P. Ryan, Carlos Fernández‐del Castillo, Theodore S. Hong, Mikäel J. Pittet, Rakesh K. Jain   +17 more
openalex   +1 more source

Faculty Opinions recommendation of Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation.

, 2011
John S. Lazo
openalex   +2 more sources

Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT? [PDF]

, 2001
McMurray, John J.V.
core   +1 more source

Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats

Journal of Applied Oral Science
Hypertension is one of the main causes of premature death in the world; also, it is associated with several bone alterations. Preclinical studies have demonstrated delayed alveolar bone healing in hypertensive rats.
Gabriel Mulinari-Santos, Jaqueline Silva dos Santos, Letícia Pitol Palin, Ana Cláudia Ervolino da Silva, Cristina Antoniali, Leonardo Perez Faverani, Roberta Okamoto   +6 more
doaj   +1 more source

Angiotensin-converting enzyme inhibitors but not angiotensin II AT 1 receptor antagonists affect erythropoiesis in patients with anemia of end-stage renal disease [PDF]

, 1999
Lang, Susanne M., Schiffl, Helmut
core   +1 more source

Optimizing Blood Pressure Control: A Randomized Comparative Trial of Losartan/Chlorthalidone vs. Losartan/Hydrochlorothiazide

Cardiology and Therapy
Introduction Cardiovascular diseases are a leading cause of global mortality, with hypertension as a major risk factor. Low control rates are often attributed to monotherapy, while evidence and clinical guidelines support the effectiveness of combination
Isabel E. Rucker-Joerg, Ernesto G. Cardona-Muñoz, Francisco G. Padilla-Padilla, Rodrigo Suarez-Otero, Yulia Romero-Antonio, Emmanuel Canales-Vázquez, Kevin F. Rios-Brito, Ileana C. Rodríguez-Vazquez, Jorge González-Canudas   +8 more
doaj   +1 more source

Management of Proteinuria in Dogs and Cats with Chronic Kidney Disease [PDF]

, 2016
Atkins, Bakris, Bianchi, Bomback, Brown, Brown, Brown, Brown, Bugbee, Christ, Finco, Grauer, Grauer, Horita, Jacob, Jenkins, Jepson, Jepson, Jonathan Elliott, King, King, Laverman, Lees, Lefebvre, LeVine, Linas, Littman, Maack, McAlister, Mizutani, Nabity, Nakamura, Pollock, Pressler, Ryan, Schjoedt, Schneider, Segev, Segev, Sent, Shelly L. Vaden, Singh, Syme, Tenhundfeld, Toblli, Vaden, Wehner   +46 more
core   +2 more sources